BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,59 € ↑0,90 (1,97%)
2026-06-04
AKTIENPREIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,321,665 shares
Latest Disclosed Value $ 74,660,928
Morgan Stanley reports 42.92% decrease in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,321,665 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $63,413,487 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 2,315,620 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -42.92% during the quarter. The current value of the position is $61,576,372 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,321,665 -993,955 -42.92 74,661 -45.75 0.0045
2026-05-27 2025-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 2,315,620 935,176 67.74 137,617 84.07 0.0082
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,315,620 935,176 137,617 0.0082
2026-05-27 2025-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,380,444 -1,048,245 -43.16 74,765 -44.00 0.0045
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,380,444 -1,048,245 74,765 0.0045
2025-08-15 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,428,689 1,385,804 132.88 133,505 81.09 0.0087
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,042,885 -297,547 -22.20 73,722 -16.33 0.0053
2025-05-15 2024-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,340,432 470,208 54.03 88,107 44.04 0.0062
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,340,432 470,208 88,107 0.0062
2025-05-14 2024-09-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 870,224 -326,539 -27.29 61,168 -37.92 0.0044
2025-02-14 2024-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 870,224 -326,539 61,168 0.0044
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 870,224 -326,539 61,168 0.0005
2025-05-14 2024-06-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 1,196,763 186,514 18.46 98,530 11.67 0.0076
2024-10-17 2024-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,196,763 186,514 98,530 0.0076
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,196,763 186,514 98,530 0.0076
2024-10-17 2024-03-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 1,010,249 69,877 7.43 88,235 -2.69 0.0071
2024-08-16 2024-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,010,249 69,877 88,235 0.0071
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,010,249 69,877 88,235 0.0071
2024-08-16 2023-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 940,372 178,865 23.49 90,671 34.57 0.0080
2024-02-13 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 940,372 178,865 90,671 0.0080
2023-11-15 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 761,507 -124,714 -14.07 67,378 -12.29 0.0069
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 886,221 -2,262 -0.25 76,818 -11.09 0.0076
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 888,483 -206,873 -18.89 86,396 -23.78 0.0093
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,095,356 276,841 33.82 113,359 63.38 0.0129
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 818,515 -225,802 -21.62 69,385 -19.83 0.0095
2022-10-27 2022-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,044,317 391,301 59.92 86,542 71.89 0.0112
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,044,317 391,301 86,542 0.0112
2022-10-27 2022-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 653,016 222,564 51.70 50,348 32.39 0.0068
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 653,016 222,564 50,348 0.0068
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 430,452 -327,622 -43.22 38,029 -35.09 0.0047
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 758,074 17,576 2.37 58,591 -5.17 0.0079
2021-08-23 2021-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 740,498 -40,727 -5.21 61,788 4.74 0.0082
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 740,498 -40,727 61,788 0.0017
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 781,225 120,926 18.31 58,991 1.88 0.0087
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 660,299 139,166 26.70 57,903 46.05 0.0089
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 521,133 -51,593 -9.01 39,647 -43.87 0.0077
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 572,726 25,986 4.75 70,639 52.90 0.0156
2020-05-26 2020-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 546,740 88,791 19.39 46,199 19.32 0.0126
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 546,740 88,791 46,199 3,549.0463
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 457,949 -13,530 -2.87 38,719 21.84 0.0090
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 471,479 -85,137 -15.30 31,778 -33.34 0.0084
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 556,616 217,847 64.31 47,675 58.44 0.0127
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 338,769 -257,205 -43.16 30,091 -40.71 0.0085
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 595,974 150,165 33.68 50,748 17.39 0.0152
2019-04-23 2018-09-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 445,809 -141,367 -24.08 43,229 -21.84 0.0108
2018-11-20 2018-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 445,809 0 43,229 0.0108
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 445,809 -141,367 43,229
2019-04-23 2018-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 587,176 123,430 26.62 55,311 47.12 0.0149
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 587,176 123,430 55,311
2019-04-23 2018-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 463,746 -9,018 -1.91 37,597 -10.81 0.0104
2018-05-14 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 463,746 -9,018 37,597
2019-04-23 2017-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 472,764 49,096 11.59 42,156 6.91 0.0115
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 472,764 49,096 42,156
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 423,668 -35,600 -7.75 39,431 -5.46 0.0118
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 459,268 52,008 12.77 41,710 16.67 0.0126
2017-05-22 2017-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 407,260 36,286 9.78 35,750 16.33 0.0110
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 407,260 35,750
2017-02-22 2016-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 370,974 -31,668 -7.87 30,732 -17.50 0.0101
2017-02-13 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 370,974 30,732
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 402,642 84,868 26.71 37,252 50.68 0.0127
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 317,774 -49,665 -13.52 24,723 -18.42 0.0089
2016-05-12 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 367,439 127,720 53.28 30,306 20.68 0.0117
2016-02-09 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 239,719 -124,174 -34.12 25,113 -34.48 0.0091
2016-02-08 2015-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 363,893 83,877 29.95 38,326 0.07 0.0142
2015-11-09 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 363,893 38,326
2015-08-12 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 280,016 -54,482 -16.29 38,300 -8.12 0.0133
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 334,498 -22,419 -6.28 41,684 29.19 0.0154
2015-02-13 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 356,917 -116,677 -24.64 32,265 -5.59 0.0118
2014-12-16 2014-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 473,594 80,616 20.51 34,175 39.79 0.0131
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 473,594 34,175
2014-08-12 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 392,978 40,624 11.53 24,448 1.72 0.0418
2014-05-13 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 352,354 -26,875 -7.09 24,034 -9.91 0.0101
2014-02-13 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 379,229 41,310 12.22 26,678 9.39 0.0113
2013-11-13 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 337,919 218,397 182.73 24,387 266.06 0.0115
2013-08-08 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 119,522 119,522 6,662 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.